Education
About Us
Working with TipRanks
Follow Us
Optimizerx Corporation (OPRX)
:OPRX
OPRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.78 - $18.22
Previous CloseN/A
Volume200.46K
Average Volume (3M)363.98K
Market Cap
$326.93M
Enterprise Value$269.10M
Total Cash (Recent Filing)$16.57M
Total Debt (Recent Filing)$32.80M
Price to Earnings (P/E)―
Beta2.11
Next Earnings
Nov 11, 2025EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.24
Shares Outstanding18,565,033
10 Day Avg. Volume345,175
30 Day Avg. Volume363,980
Financial Highlights & Ratios
PEG Ratio-0.65
Price to Book (P/B)0.76
Price to Sales (P/S)0.97
P/FCF Ratio18.61
Enterprise Value/Market Cap0.82
Enterprise Value/Revenue2.85
Enterprise Value/Gross Profit4.53
Enterprise Value/Ebitda-42.93
Forecast
1Y Price Target
$20.70Price Target Upside18.08% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Debt ManagementAccelerated debt paydown is fueled by strong EBITDA performance.
Financial PerformanceInvestors reacted favorably to OptimizeRx's strong underlying growth momentum and revised guidance.
Market PositionThe stock has been a year-to-date winner, with shares up 164%, indicating strong market performance.
Bears Say
Revenue GuidanceGuidance implies a significant sequential decline in third-quarter revenue, which is not the typical seasonal pattern.
Revenue SurpriseFrom investors' perspective, the decision to exit the managed services part of the Medicx acquisition was an unforeseen top-line surprise.
OptimizeRx News
OPRX FAQ
What was Optimizerx Corporation’s price range in the past 12 months?
Optimizerx Corporation lowest stock price was $3.78 and its highest was $18.22 in the past 12 months.
What is Optimizerx Corporation’s market cap?
Optimizerx Corporation’s market cap is $326.93M.
When is Optimizerx Corporation’s upcoming earnings report date?
Optimizerx Corporation’s upcoming earnings report date is Nov 11, 2025 which is in 75 days.
How were Optimizerx Corporation’s earnings last quarter?
Optimizerx Corporation released its earnings results on Aug 07, 2025. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.017 by $0.223.
Is Optimizerx Corporation overvalued?
According to Wall Street analysts Optimizerx Corporation’s price is currently Undervalued.
Does Optimizerx Corporation pay dividends?
Optimizerx Corporation does not currently pay dividends.
What is Optimizerx Corporation’s EPS estimate?
Optimizerx Corporation’s EPS estimate is 0.04.
How many shares outstanding does Optimizerx Corporation have?
Optimizerx Corporation has 18,565,033 shares outstanding.
What happened to Optimizerx Corporation’s price movement after its last earnings report?
Optimizerx Corporation reported an EPS of $0.24 in its last earnings report, beating expectations of $0.017. Following the earnings report the stock price went up 34.735%.
Which hedge fund is a major shareholder of Optimizerx Corporation?
Currently, no hedge funds are holding shares in OPRX
OptimizeRx Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.70 (18.08% Upside)
$20.70 (18.08% Upside)
Blogger Sentiment
Bullish
OPRX Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 203.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.6%
Last 30 Days ▲ 15.2%
Last 30 Days ▲ 15.2%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
112.74%
12-Months-Change
Fundamentals
Return on Equity
-8.21%
Trailing 12-Months
Asset Growth
-2.09%
Trailing 12-Months
Company Description
Optimizerx Corporation
OptimizeRx (OPRX) is a healthcare technology company that operates in the digital health sector, focusing on improving patient outcomes through its innovative platform. The company provides a suite of solutions designed to enhance patient access to medications and streamline communication between healthcare providers, patients, and pharmaceutical companies. OptimizeRx's core products include electronic health record (EHR) integrations that facilitate the delivery of patient savings programs and medication information directly within the clinical workflow, thereby enhancing the prescribing process and adherence to treatment regimens.
OPRX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook with strong revenue growth, improved adjusted EBITDA, and significant debt reduction. However, some caution was noted regarding the uncertainty of managed service revenue continuing at the same rate. Overall, the company appears to be on a strong growth trajectory with a solid financial position.View all OPRX earnings summariesOPRX Stock 12 Month Forecast
Average Price Target
$20.70
▲(18.08% Upside)
Technical Analysis
Health Catalyst
―
American Well
―
SOPHiA GENETICS
―
Definitive Healthcare Corp
―
EUDA Health Holdings
―
Ownership Overview
8.90% Insiders
15.92% Mutual Funds
30.00% Other Institutional Investors
36.02% Public Companies and
Individual Investors